Literature DB >> 9580922

Bi-level positive airway pressure treatment of obstructive sleep apnoea syndrome.

S B Laursen1, B Dreijer, C Hemmingsen, E Jacobsen.   

Abstract

We evaluated the effect of non-invasive nocturnal ventilation with the bi-level positive airway pressure (BiPAP) ventilator in 12 overweight patients with verified obstructive sleep apnoea syndrome (OSAS) and nocturnal hypercapnia. All patients exhibited subsequently less overnight CO2 accumulation (p < 0.0001), the desaturation event frequency was reduced (p < 0.002), daytime O2 tension rose (p < 0.001), daytime CO2 tension was reduced (p < 0.01), and apnoeas were eliminated. All symptoms characterising the syndrome, when present at the beginning of the therapy, were eliminated during the treatment. Patient compliance was high. This study showed that OSAS patients with hypercapnia can be effectively treated by BiPAP ventilation during sleep.

Entities:  

Mesh:

Year:  1998        PMID: 9580922     DOI: 10.1159/000029241

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids.

Authors:  Michelle Cao; Chia-Yu Cardell; Leslee Willes; June Mendoza; Adam Benjafield; Clete Kushida
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

2.  Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea).

Authors:  Dominic Dellweg; Jens Kerl; Ekkehard Hoehn; Markus Wenzel; Dieter Koehler
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

3.  Correlates of a prescription for Bilevel positive airway pressure for treatment of obstructive sleep apnea among veterans.

Authors:  Skai W Schwartz; Julie Rosas; Michelle R Iannacone; Philip R Foulis; W McDowell Anderson
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

4.  [Cataract surgery in a patient with severe obstructive sleep apnea syndrome].

Authors:  A Reber; T Ursprung
Journal:  Anaesthesist       Date:  2003-11       Impact factor: 1.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.